Cumberland Pharmaceuticals Inc. Proceeds from Long-term Lines of Credit
Cumberland Pharmaceuticals Inc. (CPIX) reported Proceeds from Long-term Lines of Credit of -$500.00 thousand for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2012-08-09
- Cumberland Pharmaceuticals Inc. proceeds from long-term lines of credit for the quarter ending 2012-06-30 was -$750.00K.
- Cumberland Pharmaceuticals Inc. proceeds from long-term lines of credit for the quarter ending 2012-03-31 was $250.00K.
- Cumberland Pharmaceuticals Inc. proceeds from long-term lines of credit for the quarter ending 2011-12-31 was $284.00K.
- Cumberland Pharmaceuticals Inc. proceeds from long-term lines of credit for fiscal 2011 was $3.03M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$500.00K 10-Q · filed 2012-08-09 | -$216.00K derived: sum of 3 quarters · filed 2012-08-09 | |
| 2012-03-31 | $250.00K 10-Q · filed 2012-05-04 | $534.00K derived: sum of 2 quarters · filed 2012-05-04 | ||
| 2011-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-07 | $3.03M 10-K · filed 2012-03-07 | ||
| 2011-09-30 | $2.75M 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |